Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Ozempic & NAION: EU Safety Panel Continues Probe Into Link With Eye Condition
Jan 03 2025
•
By
Neena Brizmohun
The EMA is investigating whether Ozempic increases the risk of developing a rare eye condition
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Drug Safety
More from Geography